Study details
Enrolling now
Cannabis Effects as a Function of Sex
University of California, Los Angeles
NCT IDNCT04385082ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
160
Study length
about 5 years
Ages
21–55
Locations
1 site in CA
About this study
This trial is testing how cannabis affects pain relief and addiction risk in both men and women. Participants will receive either active cannabis or a placebo, and it will last for 1818 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Active Cannabis
- 2.Take Placebo Cannabis
PhasePhase 1
DrugActive Cannabis
Primary goalPharmacokinetics of THC and metabolites
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
cannabinoid
Endpoints
Primary: Pharmacokinetics of THC and metabolites